Educational Symposium

Acute and Chronic Hyperkalemia: An Update on Management

November 07, 2019 | 12:45 PM - 01:45 PM

Location: Marquis Ballroom, Salon 10, Marriott Marquis

Session Description

Hyperkalemia is a common and potentially fatal electrolyte abnormality in CKD. There have been challenges to the traditional views that hyperkalemia can be reliably diagnosed by electrocardiogram and that particular levels of hyperkalemia confer cardiotoxic risk. The clinical context in which hyperkalemia develops might be at least as important as the degree of hyperkalemia in determining patient outcome.

This symposium provides an update on recent advances in the treatment of acute and chronic hyperkalemia. The role of hyperkalemia as a limiting factor in the use of RAAS blockers in CKD and mitigation strategies to address hyperkalemia are also discussed.

Support is provided by an educational grant from AstraZeneca Pharmaceuticals LP.

Learning Objective(s)

  • Describe the pathophysiology of hyperkalemia
  • Identify individuals at risk of developing hyperkalemia
  • Develop effective prevention and treatment strategies for management of acute and chronic hyperkalemia

Learning Pathway(s)

  • Chronic Kidney Disease


  • Manoocher Soleimani, MD


  • Introduction
    12:45 PM - 12:55 PM
    Manoocher Soleimani, MD
  • How Dangerous Is Hyperkalemia?
    12:55 PM - 01:15 PM
    John Ross Montford, MD
  • Therapeutic Interventions for the Prevention and Treatment of Hyperkalemia
    01:15 PM - 01:35 PM
    Linda F. Fried, MD, MPH, FASN
  • Questions and Answers
    01:35 PM - 01:45 PM